A Call to Collaborative Action – Shielding the Diabetes Patient from Micro- and Macrovascular Risks with GLP-1 Receptor Agonists

SUPPPORT STATEMENT
Supported by an independent educational grant from Novo Nordisk

Chair: Naveed Sattar (UK)

18:15 – 18:30

The Endocrinologist in the Lead

The Right Drug for the Right Patient at the Right Time

Panel Discussion:
lead by Naveed Sattar (UK)

 

18:30 – 18:45

The Cardiologist in the Lead

Primary and Secondary Cardiovascular Protection

Panel Discussion:
lead by Mark Petrie (UK)

18:45 – 19:00

The Primay Care Physician in the Lead

Implementing Proactive Diabetes Care across the Stages

Panel Discussion:
lead by Kamlesh Khunti (UK)

19:00 – 19:15

Panel Discussion and live Q&A

All Faculty 

19:15

Adjourn